Nina Linde

1.2k total citations
17 papers, 884 citations indexed

About

Nina Linde is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Nina Linde has authored 17 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Nina Linde's work include Sarcoma Diagnosis and Treatment (4 papers), Gastrointestinal Tumor Research and Treatment (4 papers) and Cancer Cells and Metastasis (4 papers). Nina Linde is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Gastrointestinal Tumor Research and Treatment (4 papers) and Cancer Cells and Metastasis (4 papers). Nina Linde collaborates with scholars based in Germany, United States and Belgium. Nina Linde's co-authors include Julio A. Aguirre‐Ghiso, Margareta M. Mueller, Georg Fluegen, Sofia Depner, Wiltrud Lederle, Nico van Rooijen, María Casanova-Acebes, Adeeb Rahman, Arthur Mortha and Eduardo Farias and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Nina Linde

16 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nina Linde Germany	10	452	379	346	160	118	17	884
Ruoyu Ma China	8	360 0.8×	372 1.0×	345 1.0×	130 0.8×	90 0.8×	10	809
Nathalie Harrer Austria	15	312 0.7×	398 1.1×	428 1.2×	137 0.9×	126 1.1×	19	1.0k
Paulina Pathria United States	5	378 0.8×	625 1.6×	361 1.0×	146 0.9×	129 1.1×	5	992
Sugandha Saxena United States	14	438 1.0×	407 1.1×	228 0.7×	103 0.6×	64 0.5×	28	832
Lilach Abramovitz Israel	11	376 0.8×	245 0.6×	452 1.3×	165 1.0×	94 0.8×	13	967
Abhijit Aithal United States	12	372 0.8×	218 0.6×	428 1.2×	163 1.0×	77 0.7×	23	809
Denarda Dangaj Laniti Switzerland	15	703 1.6×	544 1.4×	367 1.1×	186 1.2×	128 1.1×	31	1.1k
Iris de Rink Netherlands	11	348 0.8×	305 0.8×	478 1.4×	161 1.0×	39 0.3×	19	882
Deblina Raychaudhuri India	11	461 1.0×	604 1.6×	408 1.2×	173 1.1×	99 0.8×	17	1.2k

Countries citing papers authored by Nina Linde

Since Specialization

Citations

This map shows the geographic impact of Nina Linde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Linde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Linde more than expected).

Fields of papers citing papers by Nina Linde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Linde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Linde. The network helps show where Nina Linde may publish in the future.

Co-authorship network of co-authors of Nina Linde

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Linde. A scholar is included among the top collaborators of Nina Linde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Linde. Nina Linde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Esdar, Christina, Nina Linde, Andreas Blum, et al.. (2025). M4205 (IDRX-42) Is a Highly Selective and Potent Inhibitor of Relevant Oncogenic Driver and Resistance Variants of KIT in Cancer. Molecular Cancer Therapeutics. 24(7). 1040–1053. 1 indexed citations

Linde, Nina, et al.. (2024). Agricultural Technologies as a Tool for Integrating Artificial Intelligence into the Agricultural Infrastructure of Ukraine. 7(3). s30–s51.

Linde, Nina, et al.. (2024). Artificial Intelligence in Waste Management in the Context of Implementing Circular Economy. 7(3). s149–s172. 1 indexed citations

Woźniak, Agnieszka, Ulla Vanleeuw, Nina Linde, et al.. (2023). Antitumor Efficacy of the Novel KIT Inhibitor IDRX-42 (Formerly M4205) in Patient- and Cell Line–Derived Xenograft Models of Gastrointestinal Stromal Tumor (GIST). Clinical Cancer Research. 29(15). 2859–2868. 9 indexed citations

Blum, Andreas, Dieter Dorsch, Nina Linde, et al.. (2023). Identification of M4205─A Highly Selective Inhibitor of KIT Mutations for Treatment of Unresectable Metastatic or Recurrent Gastrointestinal Stromal Tumors. Journal of Medicinal Chemistry. 66(4). 2386–2395. 8 indexed citations

Woźniak, Agnieszka, Ulla Vanleeuw, Nina Linde, et al.. (2022). Abstract 2666: Anti-tumor effects of the novel KIT mutant inhibitor M4205 in patient-derived gastrointestinal stromal tumor (GIST) xenograft models. Cancer Research. 82(12_Supplement). 2666–2666. 2 indexed citations

Viteri, Santiago, Christopher Stroh, Nina Linde, et al.. (2020). SHP2 Inhibition Influences Therapeutic Response to Tepotinib in Tumors with MET Alterations. iScience. 23(12). 101832–101832. 8 indexed citations

Grädler, Ulrich, Michael Busch, Birgitta Leuthner, et al.. (2020). Biochemical, cellular and structural characterization of novel and selective ERK3 inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(22). 127551–127551. 9 indexed citations

Stroh, Christopher, Nina Linde, Michael P. Sanderson, et al.. (2020). Abstract 3774: Unraveling mechanisms of resistance to tepotinib and future treatment options. Cancer Research. 80(16_Supplement). 3774–3774. 1 indexed citations

10.

Linde, Nina, María Casanova-Acebes, María Soledad Sosa, et al.. (2017). Macrophages orchestrate breast cancer early dissemination and metastasis. Nature Communications. 9(1). 21–21. 318 indexed citations

11.

Linde, Nina, Georg Fluegen, & Julio A. Aguirre‐Ghiso. (2016). The Relationship Between Dormant Cancer Cells and Their Microenvironment. Advances in cancer research. 132. 45–71. 131 indexed citations

12.

Linde, Nina, et al.. (2012). Vascular endothelial growth factor‐induced skin carcinogenesis depends on recruitment and alternative activation of macrophages. The Journal of Pathology. 227(1). 17–28. 157 indexed citations

13.

Linde, Nina, et al.. (2012). Integrating Macrophages into Organotypic Co-Cultures: A 3D In Vitro Model to Study Tumor-Associated Macrophages. PLoS ONE. 7(7). e40058–e40058. 91 indexed citations

14.

Linde, Nina, et al.. (2012). GM‐CSF enhances tumor invasion by elevated MMP‐2, ‐9, and ‐26 expression. Cancer Medicine. 2(2). 117–129. 77 indexed citations

15.

Depner, Sofia, et al.. (2012). Cell type specific interleukin-6 induced responses in tumor keratinocytes and stromal fibroblasts are essential for invasive growth. International Journal of Cancer. 135(3). 551–562. 22 indexed citations

16.

Lederle, Wiltrud, Nina Linde, Jessica Bzyl, et al.. (2009). Platelet-Derived Growth Factor-B Normalizes Micromorphology and Vessel Function in Vascular Endothelial Growth Factor-A-Induced Squamous Cell Carcinomas. American Journal Of Pathology. 176(2). 981–994. 28 indexed citations

17.

Botha, Alfred, J.L.F. Kock, D.J. Coetzee, Nina Linde, & M. S. Van Dyk. (1992). Yeast Eicosanoids II. The Influence of Non-Steroidal Anti-Inflammatory Drugs on the Life Cycle of Dipodascopsis. Systematic and Applied Microbiology. 15(1). 155–160. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact